Stocks and Investing Stocks and Investing
Fri, October 20, 2023

Mayank Mamtani Maintained (TGTX) at Strong Buy with Decreased Target to $24 on, Oct 20th, 2023


Published on 2024-10-28 06:59:28 - WOPRAI, Mayank Mamtani
  Print publication without navigation


Mayank Mamtani of B. Riley Securities, Maintained "TG Therapeutics, Inc." (TGTX) at Strong Buy with Decreased Target from $32 to $24 on, Oct 20th, 2023.

Mayank has made no other calls on TGTX in the last 4 months.



There are 3 other peers that have a rating on TGTX. Out of the 3 peers that are also analyzing TGTX, 1 agrees with Mayank's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Corinne Jenkins of "Goldman Sachs" Maintained at Hold with Decreased Target to $12 on, Thursday, August 3rd, 2023


These are the ratings of the 2 analyists that currently disagree with Mayank


  • Edward White of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $41 on, Monday, September 18th, 2023
  • Eric Joseph of "JP Morgan" Maintained at Buy with Decreased Target to $22 on, Monday, August 7th, 2023

Contributing Sources